$0
Estimated platform fees over 24 months
$0 setup + $0/month x 24 months
- 1 active study
- 1 site
- 1 depot
- 50 subjects
Does not fit this five-site study. Try this tier only within its limits.
Try Free within its limits →Configure your protocol, not a software development project. Agilix RTSM puts guided study setup, randomization, dosing and clinical supply in your team's hands—with the knowledge and quality documentation to support every step.
Choose Agilix RTSM for a self-service approach: one configurable platform, guided setup, practical learning resources and a documented quality foundation. Keep study decisions with the people who know your protocol, with supported setup handled through reviewed configuration rather than per-study software builds.
Authorized sponsor, CRO, university and investigator-led teams configure products, arms, visits, dosing, cohorts and stratification themselves. Supported protocol settings do not require a separate code build for each study.
A ten-step study design workflow takes you from investigational products to design approval and master randomization. Page-specific Help explains fields and gives worked examples while you configure.
Follow the setup steps →Search task-focused guides for setup, dispensing, supply, audit review and study lifecycle. Learn the prerequisites, field meanings, procedures and expected outcomes before taking action.
Explore the knowledge base →The project documentation set covers requirements, design, Part 11 assessment, validation planning, code review, developer tests, integration testing, traceability and release records. Review the evidence and its scope with your quality team.
See the validation foundation →Free, Basic, Silver and Gold include the same platform features. Choose capacity for your Account's studies, sites, depots and subjects; change tier as your needs change rather than buying feature unlocks.
Compare a two-year study →Your organization controls its study configuration and authorized users. Approved revisions, signed actions, audit history and permission-scoped exports keep that ownership connected to evidence.
Explore the platform →Configure the supported methods around your approved protocol. Study, site and subject capacity changes by plan; the design and operational capabilities do not.
Permuted-block randomization with treatment ratios and compatible block sizes, or Pocock-Simon minimization with configured balancing factors and imbalance controls.
Define stratification factors and their levels, and manage cohorts with enrollment caps and Open, Paused or Closed status. Cohort availability and eligibility are checked before allocation.
Fixed, weight-based, body-surface-area (BSA), bracketed, titration and biomarker-adaptive dosing. Saved protocol rules define dose calculations and product quantities.
Scheduled, product-specific visit dispensing and protocol-enabled unscheduled dispensation. Support treatment products and additional non-treatment products, with physical verification kept separate from issuance.
Individually tracked kits for multi-arm supply, and quantity-tracked stock for single-arm and non-randomized products. Configure persistent two-arm crossover visits where the protocol requires them.
Generate and review a separate DUMMY randomization schedule without assigning subjects. Create the operational master from the approved design; eligible unchanged designs can reuse reviewed DUMMY settings. Export schedules for review, with generation provenance retained.
Register an Account and begin on Free. Access to study workflows follows execution of the customer agreements; clinical activation follows approval and QA release, not registration alone.
Create your Account, verify your email and execute the four customer agreements.
Invite users, set roles, add sites and depots, and follow the guided study design.
Review the DUMMY schedule, obtain second-person design approval and prepare the master. Execute the revision-linked UAT package and obtain QA release.
With organizational readiness confirmed, activate the approved study and manage subjects, dispensing and supply.
Agilix's quality documentation and technical controls support your assessment; they are not automatic regulatory certification. Your organization approves its protocol configuration, intended-use validation, training, procedures and deployment qualification before clinical use.
Understand quality responsibilities →Illustrative study: 24 calendar months, 1 active study, 5 sites, 1 depot and 50 subjects. These are planning assumptions, not a claim about the average clinical trial. Capacity is shared across your Account.
Estimated platform fees over 24 months
$0 setup + $0/month x 24 months
Does not fit this five-site study. Try this tier only within its limits.
Try Free within its limits →Estimated platform fees over 24 months
$2,000 setup + $800/month x 24 months
Smallest published tier that fits this study.
Start free, choose your scale →Estimated platform fees over 24 months
$5,000 setup + $3,500/month x 24 months
Fits this study, with additional Account capacity.
Start free, choose your scale →Estimated platform fees over 24 months
$10,000 setup + $8,500/month x 24 months
Fits this study, with additional Account capacity.
Start free, choose your scale →Calculated from the current published tier settings. USD, excluding applicable taxes. Totals assume a new Account's one-time setup fee plus 24 months at the same tier, with no tier changes. Paid setup applies the first time an Account moves to a paid tier; the highest tier held in a calendar month determines that month's fee. This is a platform subscription estimate, not the full cost of conducting a trial or a binding quote. Platinum is available by contract.
Build confidence with practical guides and a documented quality foundation. Use the knowledge base for day-to-day setup and operations; use the Trust Center to understand validation evidence and responsibilities.
Browse the knowledge base →Start on Free, explore the guidance and see how your protocol fits. Choose a paid tier when your Account needs more capacity—not to unlock the study tools.